Absorption of leucovorin (NSC-3590) from a "mouthwash"
Bruckner, H.W.; Bertino, J.R.
Cancer ChemoTherapy Reports 59(3): 575-576
1975
ISSN/ISBN: 0069-0112 PMID: 1081907 Document Number: 83154
Document emailed within 1 workday
Related Documents
Yuasa, C.; Okabe, H.; Toko, T.; Takeda, S.; Unemi, N. 1995: Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(13): 1927-1932Okabo, S.; Arai, T.; Maruyama, S.; Lee, M.; Murase, N.; Tsubaki, M.; Endo, M.; Wada, Y.; Shimoju, K.; Sakurazawa, K.; Sugihara, K.; Maruyama, M.; Yabata, E.; Kawasaki, T.; Sasaki, T. 1997: A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 849-854
Sasaki, T.; Ota, K.; Taguchi, T.; Ogawa, N.; Kurihara, M.; Akazawa, S.; Ogawa, M.; Tominaga, T.; Konishi, T.; Kumai, K. 1995: A randomized early phase Ii study of l-leucovorin and 5-fluorouracil in gastric cancer. l-Leucovorin and 5-FU Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 521-529
Smith, R.E.; Lembersky, B.C.; Wieand, H.S.; Colangelo, L.; Mamounas, E.P. 2000: UFT/leucovorin vs 5-FU/leucovorin in colon cancer Oncology 14(10 Suppl 9: 24-27
Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333
Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Wynder, E.L.; Kabat, G.; Rosenberg, S.; Levenstein, M. 1983: Oral cancer and mouthwash use Journal of the National Cancer Institute 70(2): 255-260
Van der Vliet, W.; Erlichman, C.; Elhakim, T. 1989: Allopurinol mouthwash for prevention of fluorouracil-induced stomatitis Clinical Pharmacy 8(9): 655-658
Moustafa, M.H.; Abd el-All, M.M.; Abo el-Fadl, K.M. 1987: Reduced plaque formation by miswak-based mouthwash Egyptian Dental Journal 33(4): 375-384
Shirodaria, S.; Kilbourn, T.; Butler, A.; Middleton, S. 2006: Subjective assessment of a new moisturizing mouthwash for the symptomatic management of dry mouth Journal of Clinical Dentistry 17(2): 39-44
Tramèr, M.; Bassetti, C.; Metzler, C.; Morgantini, A. 2001: Efficacy and safety of mouthwash diclofenac in oral or periodontal surgery Minerva Stomatologica 50(9-10): 309-314
Esteva Cantó, M.; March Cerdá, J.C.; Abraham Paris, C.; Quintana Torres, L.; Botey Ornedal, A.; Ferrer Riera, J.; Marí Torres, G. 1991: Community trial for the evaluation of the fluoride mouthwash program among students in Palma de Mallorca Atencion Primaria 8(11): 928-931
Schmidt, H.; Hampel, C.M.; Schmidt, G.; Riess, E.; Rödel, C. 1980: Double-blind trial of the effect of a propolis-containing mouthwash on inflamed and healthy gingiva Stomatologie der DDR 30(7): 491-497
Cooper, L.; Komarov, G.N.; Shaw, K.E.; Pretty, I.A.; Ellwood, R.P.; Birkhed, D.; Smith, P.W.; Flannigan, N.L.; Higham, S.M. 2012: Effect of post-brushing mouthwash solutions on salivary fluoride retention--study 2 Journal of Clinical Dentistry 23(3): 92-96
Plagmann, H.C.; Schwardmann, F. 1985: The inhibitory effect of antiseptic mouthwash solutions on bacterial growth in dental plaque and saliva Deutsche Zahnarztliche Zeitschrift 40(7): 806-810
Fujimura, T.; Shima, Y.; Sawasaki, K.; Haryo, S.; Fujita, H.; Anada, E.; Shiota, S. 1991: Prophylactic effect of allopurinol mouthwash against stomatitis induced by the chemotherapy (PMUE regimen) for gastrointestinal malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(14): 2463-2466
Varoni, E.M.; Gargano, M.; Ludwig, N.; Lodi, G.; Sardella, A.; Carrassi, A. 2017: Efficacy of an anti-discoloration system (ADS) in a 0.12% chlorhexidine mouthwash: a triple blind, randomized clinical trial American Journal of Dentistry 30(5): 235-242
Keilin, D.; Hartree, E.F. 1949: Effect of low temperature on the absorption spectra of haemoproteins; with observations on the absorption spectrum of oxygen Nature 164(4163): 254-259
Gamot, A.; Guisez, N.; Mulleman, J.; Traisnel, M. 1971: Absorption capacity of active carbons and their pharmaceutic forms. 3. Interpretation of experimental curves of absorption Journal de Pharmacie de Belgique 26(5): 548-554
Pütter, J. 1970: Studies on absorption of salicylates. 2. Percutaneous absorption of salicylic acid 2'-hydroxyethyl ester following topic administration Arzneimittel-Forschung 20(11): 1721-1723